Tau PET tracers exhibit varying levels of specific signal and distinct off-target binding patterns that are more diverse than amyloid PET tracers. This study compared 2 frequently used tau PET tracers, 18F-flortaucipir and 18F-MK-6240, in the same subjects. Methods: 18F-flortaucipir and 18F-MK-6240 scans were collected within 2 mo in 15 elderly subjects varying in clinical diagnosis and cognition. FreeSurfer, version 5.3, was applied to 3-T MR images to segment Braak pathologic regions (I-VI) for PET analyses. Off-target binding was assessed in the choroid plexus, meninges, and striatum. SUV ratio (SUVR) outcomes were determined over 80-100 min (18F-flortaucipir) or 70-90 min (18F-MK-6240) normalized to cerebellar gray matter. Masked visual interpretation of images was performed by 5 raters for both the medial temporal lobe and the neocortex, and an overall (majority) rating was determined. Results: Overall visual ratings showed complete concordance between radiotracers for both the medial temporal lobe and the neocortex. SUVR outcomes were highly correlated (r 2 > 0.92; P ≪ 0.001) for all Braak regions except Braak II. The dynamic range of SUVRs in target regions was approximately 2-fold higher for 18F-MK-6240 than for 18F-flortaucipir. Cerebellar SUVs were similar for 18F-MK-6240 and 18F-flortaucipir, suggesting that differences in SUVRs are driven by specific signals. Apparent off-target binding was observed often in the striatum and choroid plexus with 18F-flortaucipir and most often in the meninges with 18F-MK-6240. Conclusion: Both 18F-MK-6240 and 18F-flortaucipir are capable of quantifying signal in a common set of brain regions that develop tau pathology in Alzheimer disease; these tracers perform equally well in visual interpretations. Each also shows distinct patterns of apparent off-target binding. 18F-MK-6240 showed a greater dynamic range in SUVR estimates, which may be an advantage in detecting early tau pathology or in performing longitudinal studies to detect small interval changes.
Tau PET tracers exhibit varying levels of specific signal and distinct off-target binding patterns that are more diverse than amyloid PET tracers. This study compared 2 frequently used tau PET tracers, 18F-flortaucipir and 18F-MK-6240, in the same subjects. Methods: 18F-flortaucipir and 18F-MK-6240 scans were collected within 2 mo in 15 elderly subjects varying in clinical diagnosis and cognition. FreeSurfer, version 5.3, was applied to 3-T MR images to segment Braak pathologic regions (I-VI) for PET analyses. Off-target binding was assessed in the choroid plexus, meninges, and striatum. SUV ratio (SUVR) outcomes were determined over 80-100 min (18F-flortaucipir) or 70-90 min (18F-MK-6240) normalized to cerebellar gray matter. Masked visual interpretation of images was performed by 5 raters for both the medial temporal lobe and the neocortex, and an overall (majority) rating was determined. Results: Overall visual ratings showed complete concordance between radiotracers for both the medial temporal lobe and the neocortex. SUVR outcomes were highly correlated (r 2 > 0.92; P ≪ 0.001) for all Braak regions except Braak II. The dynamic range of SUVRs in target regions was approximately 2-fold higher for 18F-MK-6240 than for 18F-flortaucipir. Cerebellar SUVs were similar for 18F-MK-6240 and 18F-flortaucipir, suggesting that differences in SUVRs are driven by specific signals. Apparent off-target binding was observed often in the striatum and choroid plexus with 18F-flortaucipir and most often in the meninges with 18F-MK-6240. Conclusion: Both 18F-MK-6240 and 18F-flortaucipir are capable of quantifying signal in a common set of brain regions that develop tau pathology in Alzheimer disease; these tracers perform equally well in visual interpretations. Each also shows distinct patterns of apparent off-target binding. 18F-MK-6240 showed a greater dynamic range in SUVR estimates, which may be an advantage in detecting early tau pathology or in performing longitudinal studies to detect small interval changes.
Authors: Abbas M Walji; Eric D Hostetler; Harold Selnick; Zhizhen Zeng; Patricia Miller; Idriss Bennacef; Cristian Salinas; Brett Connolly; Liza Gantert; Marie Holahan; Stacey O'Malley; Mona Purcell; Kerry Riffel; Jing Li; Jaume Balsells; Julie A OBrien; Stacey Melquist; Aileen Soriano; Xiaoping Zhang; Aimie Ogawa; Serena Xu; Elizabeth Joshi; Joseph Della Rocca; Fred J Hess; Joel Schachter; David Hesk; David Schenk; Arie Struyk; Kerim Babaoglu; Talakad G Lohith; Yaode Wang; Kun Yang; Jianmin Fu; Jeffrey L Evelhoch; Paul J Coleman Journal: J Med Chem Date: 2016-05-05 Impact factor: 7.446
Authors: Sergey Shcherbinin; Adam J Schwarz; Abhinay Joshi; Michael Navitsky; Matthew Flitter; William R Shankle; Michael D Devous; Mark A Mintun Journal: J Nucl Med Date: 2016-05-05 Impact factor: 10.057
Authors: Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici Journal: Brain Date: 2016-03-08 Impact factor: 13.501
Authors: William E Klunk; Robert A Koeppe; Julie C Price; Tammie L Benzinger; Michael D Devous; William J Jagust; Keith A Johnson; Chester A Mathis; Davneet Minhas; Michael J Pontecorvo; Christopher C Rowe; Daniel M Skovronsky; Mark A Mintun Journal: Alzheimers Dement Date: 2014-10-28 Impact factor: 21.566
Authors: Marta Marquié; Marc D Normandin; Avery C Meltzer; Michael Siao Tick Chong; Nicolas V Andrea; Alejandro Antón-Fernández; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik Debnath; Elizabeth A Bien; Charles R Vanderburg; Isabel Costantino; Sara Makaretz; Sarah L DeVos; Derek H Oakley; Stephen N Gomperts; John H Growdon; Kimiko Domoto-Reilly; Diane Lucente; Bradford C Dickerson; Matthew P Frosch; Bradley T Hyman; Keith A Johnson; Teresa Gómez-Isla Journal: Ann Neurol Date: 2017-01 Impact factor: 10.422
Authors: Nicolas J Guehl; Dustin W Wooten; Daniel L Yokell; Sung-Hyun Moon; Maeva Dhaynaut; Samantha Katz; Kirsten A Moody; Codi Gharagouzloo; Aurélie Kas; Keith A Johnson; Georges El Fakhri; Marc D Normandin Journal: Eur J Nucl Med Mol Imaging Date: 2019-07-22 Impact factor: 9.236
Authors: Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling Journal: Ann Neurol Date: 2015-12-15 Impact factor: 10.422
Authors: Luca Passamonti; Patricia Vázquez Rodríguez; Young T Hong; Kieren S J Allinson; David Williamson; Robin J Borchert; Saber Sami; Thomas E Cope; W Richard Bevan-Jones; P Simon Jones; Robert Arnold; Ajenthan Surendranathan; Elijah Mak; Li Su; Tim D Fryer; Franklin I Aigbirhio; John T O'Brien; James B Rowe Journal: Brain Date: 2017-03-01 Impact factor: 13.501
Authors: Tharick A Pascoal; Monica Shin; Min Su Kang; Mira Chamoun; Daniel Chartrand; Sulantha Mathotaarachchi; Idriss Bennacef; Joseph Therriault; Kok Pin Ng; Robert Hopewell; Reda Bouhachi; Hung-Hsin Hsiao; Andrea L Benedet; Jean-Paul Soucy; Gassan Massarweh; Serge Gauthier; Pedro Rosa-Neto Journal: Alzheimers Res Ther Date: 2018-07-31 Impact factor: 6.982
Authors: Greet Vanderlinden; Jenny Ceccarini; Thomas Vande Casteele; Laura Michiels; Robin Lemmens; Eric Triau; Kim Serdons; Jos Tournoy; Michel Koole; Mathieu Vandenbulcke; Koen Van Laere Journal: Mol Psychiatry Date: 2022-07-06 Impact factor: 15.992
Authors: Natasha Krishnadas; Vincent Doré; Colin Groot; Fiona Lamb; Pierrick Bourgeat; Samantha C Burnham; Kun Huang; Anita M Y Goh; Colin L Masters; Victor L Villemagne; Christopher C Rowe Journal: Alzheimers Res Ther Date: 2022-04-08 Impact factor: 8.823
Authors: Justin P Wright; Jason R Goodman; Yin-Guo Lin; Brian P Lieberman; Jennifer Clemens; Luis F Gomez; Qianwa Liang; Adam T Hoye; Michael J Pontecorvo; Kelly A Conway Journal: Eur J Nucl Med Mol Imaging Date: 2022-05-21 Impact factor: 10.057
Authors: Natasha Krishnadas; Kun Huang; Stephanie A Schultz; Vincent Doré; Pierrick Bourgeat; Anita M Y Goh; Fiona Lamb; Svetlana Bozinovski; Samantha C Burnham; Joanne S Robertson; Simon M Laws; Paul Maruff; Colin L Masters; Victor L Villemagne; Christopher C Rowe Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160